论文部分内容阅读
目的探讨舒利迭治疗儿童支气管哮喘的临床治疗效果及意义。方法 6~14岁儿童支气管哮喘60例患儿均采用准纳器吸入舒利迭(丙酸氟替卡松/沙美特罗干粉剂)治疗后观察患儿肺功能相关指标。结果观察吸入治疗2月、6月、12月后发现患儿肺功能相关系数与治疗前比较差异有显著性。患儿气喘,咳嗽症状明显改善,所有患儿没有出现哮喘持续状态等严重不良时间。结论针对儿童支气管哮喘患儿使用舒利迭治疗,可改善肺功能,可减少复发,从而可以成为治疗儿童哮喘的一种治疗方式。
Objective To investigate the clinical effect and clinical significance of seretide in children with bronchial asthma. Methods A total of 60 children with bronchial asthma aged 6-14 years were enrolled in this study. The indexes of pulmonary function in children were observed after inhalation of seretide (fluticasone propionate / salmeterol dry powder). Results Observation of inhalation therapy in February, June, December found that children with pulmonary function correlation coefficient was significantly different from before treatment. Children with asthma, cough symptoms improved significantly, all children did not appear serious conditions such as asthma sustained adverse time. Conclusions The use of seretide in children with bronchial asthma can improve pulmonary function and reduce recurrence, which can be a treatment for childhood asthma.